Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome (Q54650664)
Jump to navigation
Jump to search
scientific article published on September 15, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome |
scientific article published on September 15, 2010 |
Statements
Low-dose Nilotinib can maintain complete molecular remissions in FIP1L1/PDGFRA-positive hypereosinophilic syndrome (English)
Emeline Tabouret
Aude Charbonnier
Marie-Joelle Mozziconacci
Vadim Ivanov
15 September 2010
35
1
136